Nevro Corp (NYSE:NVRO)
| 161.13 Delayed Data As of 3:59pm ET |  -4.29 / -2.59%Today’s Change | 111.87 Today|||52-Week Range 188.14 | -6.92% Year-to-Date |
Latest NVRO News | Press Releases
| Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates 6:15pm / Zacks.com - Paid Partner Content | Analysts Estimate Nevro (NVRO) to Report a Decline in Earnings: What to Look Out for Apr 28 / Zacks.com - Paid Partner Content |
| Eos Focused Equity Management, L.P. Buys Baxter International Inc, Intel Corp, Waters Corp, ... Apr 29 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 165.42 |
| Today’s open | 165.68 |
| Day’s range | 160.96 - 165.79 |
| Volume | 317,237 |
| Average volume (3 months) | 452,207 |
| Market cap | $6.0B |
Data as of 3:59pm ET, 05/05/2021
Growth & Valuation
| Earnings growth (last year) | +26.72% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | -7.23% |
| P/E ratio | NM |
| Price/Sales | 16.10 |
| Price/Book | 15.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TNDMTandem Diabetes Care... | -2.60 | -2.84% |
| LIVNLivaNova PLC | -0.20 | -0.24% |
| ---- | ||
| IRTCiRhythm Technologies... | +2.70 | +3.75% |
Data as of 4:00pm ET, 05/05/2021
Financials
| Next reporting date | May 6, 2021 |
| EPS forecast (this quarter) | -$0.85 |
| Annual revenue (last year) | $362.0M |
| Annual profit (last year) | -$83.1M |
| Net profit margin | -22.94% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
